Summary of study characteristics for each of the included studies
| Population | |||||||
|---|---|---|---|---|---|---|---|
| Paper | Device studied | Reference standard | Number of measurements per participant | Number of participants | Male (%) | Mean age (years) | AF prevalence (%) |
| Wiesel et al11 | Omron 712C | 12-lead ECG | 2 | 450 | 59 | 69 | 12.0 |
| Stergiou et al12 | Microlife BPA100 Plus | 12-lead ECG+1-lead ECG | 3 | 73 | 66 | 71 | 37.0 |
| Wiesel et al13 | Microlife BPM BP3MQ1–2D | 12-lead ECG | 3 | 405 | 51 | 73 | 23.0 |
| Marazzi et al (a)14 | Microlife BP A200 Plus | 12-lead ECG | 1 | 503 | 54 | 67 | 20.1 |
| Marazzi et al (b)14 | Omron M6 | 12-lead ECG | 1 | 503 | 54 | 67 | 20.1 |
| Wiesel et al15 | Microlife BPM BP3MQ1–2D | ECG event monitor | 1–4 per day | 139 | 37 | 67 | 12.9 |
| Kearley et al16 | WatchBP | 12-lead ECG | 1 | 999 | 49 | 80 | 7.9 |
| Wiesel et al (a)17 | Microlife BP A200 Plus | 12-lead ECG | 3 | 183 | 59 | 74 | 16.4 |
| Wiesel et al17 (b) | Omron M6 | 12-lead ECG | 1 | 183 | 59 | 74 | 16.4 |
AF, atrial fibrillation.